Course Information

Mélanome : progrès récents en matière de prise en charge chirurgicale du mélanome primaire

Mélanome : progrès récents en matière de prise en charge chirurgicale du mélanome primaire

Ce module s’adresse aux chirurgiens qui s’intéressent aux récentes recherches soulignant la valeur pronostique de la biopsie des ganglions sentinelles et aux nouvelles données sur l’avantage que présente la lymphadénectomie totale pour la survie des patients. Dans ce module de 1 heure, vous trouverez : des résumés d’essais marquants sur le mélanome, des articles publiés pertinents et des scénarios fondés sur des cas accompagnés de rétroaction aux réponses.

Objectifs d’apprentissage :

  1. reconnaître le rôle de la biopsie des ganglions sentinelles dans la prise en charge chirurgicale du mélanome localisé;
  2. évaluer l’incidence de l’essai MSTL II sur les recommandations futures en matière de lymphadénectomie totale.

Ce programme a bénéficié de subventions à l’éducation de la part de Roche et Novartis.

Course Registration

Mélanome : progrès récents en matière de prise en charge chirurgicale du mélanome primaire

MDcme (on behalf of its consortium partners) protects the privacy of personal and other information regarding course registrants. MDcme will not release personally identifiable information to a third party without an individual's consent, except such information as is required for reporting purposes to the body or bodies accrediting this course for continuing education study credits. MDcme collects and reviews all course data (registration/course completion statistics, pre/post-test and satisfaction survey) to determine if a course meets participants' learning needs. Data is reviewed to improve existing courses and to inform the development of future course offerings. If an evaluation report is provided to a third party, all data is summarized, with no participant identifying information included. Given the importance and potential impact of some courses, evaluation data may be presented and/or published in academic venues. Again, this data is always summarized, with no identifying information included.

At times, a contributing/partner organization involved in a course may request individual participant data from pre/post or evaluation surveys for quality improvement or educational research purposes. This data would be de-identified so would not be associated with any personally identifiable information such as your name, profession, city, etc.

If requested by a contributing/partner organization:

Do you consent to the release of your individual, de-identified pre/post or evaluation survey data for the purposes of quality improvement or educational research?


×

You must have an MDcme.ca account and be logged in to register for this course


Credits

    (up to) 1 credit hours

Expiry Date

This course expires on
Thursday, July 25, 2019

    Maintenance of Certification (Section 3)
    This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Office of Professional & Educational Development, Faculty of Medicine, Memorial University. You may claim a maximum of 1 hours (credits are automatically calculated).


Comité scientifique 

  • Dre Kathryn Roth (présidente du comité scientifique), MD, FRCPC
    Professeure adjointe, Département d'otorhinolaryngologie, Université Western, London (Ontario)
  • Dr Scott Ernst, MD, FRCPC
    Chef de département, Oncologie médicale, Département d'oncologie, Université Western, London (Ontario)
  • Dr Alex Hammond, MD, BSC, MBBCH, ABRT, FRCPC
    Professeur, Département d'oncologie, Université Western, London (Ontario)
  • M. Michael Brock, MSc
    Schulich School of Medicine & Dentistry, Université Western, London (Ontario)
  • M. Michael Murray, MSc
    Schulich School of Medicine & Dentistry, Université Western, London (Ontario)

Social